Status:
COMPLETED
Trial of Vitamin D in HIV Progression
Lead Sponsor:
Harvard School of Public Health (HSPH)
Collaborating Sponsors:
Management and Development for Health (MDH)
Conditions:
HIV Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the efficacy and safety of vitamin D3 (cholecalciferol) supplementation on HIV progression and incidence of pulmonary tuberculosis among HIV-positive Tanzania...
Detailed Description
HIV-infected adults initiating antiretroviral therapy in resource-limited settings experience high mortality, pulmonary tuberculosis, and other comorbidity rates during the first year of HIV treatment...
Eligibility Criteria
Inclusion
- HIV-positive
- Men or Women
- 18 Years of Age or older
- Initiating HAART at time of randomization
- 25(OH)D concentration \<30 ng/mL at HAART initiation
Exclusion
- Pregnant Women
- Enrolled in another micronutrient trial
Key Trial Info
Start Date :
February 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2019
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT01798680
Start Date
February 1 2014
End Date
March 31 2019
Last Update
August 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Management and Development for Health (MDH)
Dar es Salaam, Tanzania